Back to Journals » OncoTargets and Therapy » Volume 12

Original Research

Serum circSETDB1 is a promising biomarker for predicting response to platinum-taxane-combined chemotherapy and relapse in high-grade serous ovarian cancer

       
Total article views   HTML views PDF downloads Totals
6,378 Dovepress* 5,778+ 824 6,602
PubMed Central* 600 155 755
Totals 6,378 979 7,357
*Since 11 September 2019

View citations on PubMed Central and Google Scholar